WallStreetZenWallStreetZen

AnalystsJohn Deakin-Bell
John Deakin-Bell's Stock Forecasts

Analyst Ranking
Bottom 36%
#2703 out of 4174 analysts
Average Return
-1.99%
Win Rate
33%1 out of 3
Risk vs Reward
Poor
Good

John Deakin-Bell's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Resmed IncRMD
+0.24%$194.75$195.22
2021-05-11 -
2022-05-10
Strong Buy

John Deakin-Bell Analyst Color

Get additional color on John Deakin-Bell's coverage of popular stocks

John Deakin-Bell's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Resmed IncRMD
3Strong BuyN/AN/AUpgrades
5 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.